PMC9035958_01
Clinical course and LP results. Month 0 denotes initiation of ibrutinib therapy. LP # 1 denotes the first LP performed after ibrutinib initiation.
cro-0015-0345-g02.jpg
PMC9035958_01_cro-0015-0345-g02.jpg
F2
Despite headache improvement on discharge, LPs performed over the next 5 months showed persistence of CLL (shown in Fig. 2). To date, a total of eight LPs have been performed since ibrutinib initiation, five of which were after the start of venetoclax (shown in Fig. 2).